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middle and inner ear of rat and transportation
pathway after transtympanic injection
Jing Zou1,5*, Markus Hannula2†, Superb Misra3,7†, Hao Feng1†, Roberto Hanoi Labrador4, Antti S Aula2,6,
Jari Hyttinen2 and Ilmari Pyykkö1Abstract
Background: Silver nanoparticles (Ag NPs) displayed strong activities in anti-bacterial, anti-viral, and anti-fungal
studies and were reportedly efficient in treating otitis media. Information on distribution of AgNPs in different
compartments of the ear is lacking.
Objective: To detect distribution of Ag NPs in the middle and inner ear and transportation pathways after
transtympanic injection.
Methods: Contrast effect of Ag NPs in the micro CT imaging was assessed in a phantom. AgNPs at various
concentrations (1.85 mM, 37.1 mM, and 370.7 mM) were administered to rat middle ear using transtympanic
injection and cadaver heads were imaged using micro CT at several time points.
Results: The lowest concentration of Ag NPs that could be visualized using micro CT was 37.1 mM. No
difference was observed between the solvents, deionized H2O and saline. Ag NPs at 37.1 mM were visible in the
middle ear on 7 d post-administration. Ag NPs at 370.7 mM generated signals in the middle ear, ossicular chain,
round window membrane, oval window, scala tympani, and Eustachian tube for both 4 h and 24 h time points.
A gradient distribution of Ag NPs from the middle ear to the inner ear was detected. The pathways for Ag NPs
to be transported from the middle ear into the inner ear are round and oval windows.
Conclusion: This study provided the imaging evidence that Ag NPs are able to access the inner ear in a dose-dependent
manner after intratympanic administration, which is relevant to design the delivery concentration in the future clinic
application in order to avoid adverse inner ear effect.
Keywords: Silver nanoparticles, Micro CT, Ear, Animal, PathwayIntroduction
Silver nanoparticles (Ag NPs) displayed strong activities
in anti-bacterial, anti-viral, and anti-fungal studies attrib-
uted to the mechanisms of inhibiting the formation of
biofilm and destroying viral structures and boosting in-
nate immune response among others [1-5]. Study per-
formed by Radzig et al. supports the hypothesis that Ag* Correspondence: Jing.Zou@uta.fi
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unless otherwise stated.NPs exert the antibacterial action through inducing gen-
eration of reactive oxygen species and causing DNA
damage by oxidative stress, which can be also involved
in the mechanisms of antiviral and antifungal activities
[6]. Ag NPs also showed excellent behavior in surface-
enhanced Raman scattering for the advanced Raman
spectroscopy, which has potential for broad range of ap-
plications in clinical molecular imaging [7].
Potentially, Ag NPs will be used to treat otitis media
and the consequential sensorineural hearing loss through
intratympanic administration. Chronic otitis media, char-
acterized by recurrent infections causing pain and puru-
lent otorrhea, is still a significant public health problem
affecting 0.5–30% of any given population in developingis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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neural hearing loss and vestibular impairment were re-
peatedly reported in the literatures [8-12]. Endolymphatic
hydrops secondary to the middle ear infection was
demonstrated in both animal model and patient with
Meniere’s disease using gadolinium enhancement mag-
netic resonance imaging (MRI) [13,14]. However, anti-
biotic is not always efficient because of the appearance
of multidrug resistant strains of bacteria. Formation of
biofilm was recently reported in the middle ear of pa-
tients with chronic otitis media all over the world
[15-18]. Through a completely different mechanism,
Ag NPs may overcome all the disadvantages of any an-
tibiotics and eliminate the microorganisms with high
efficacy in the ear therapy. This therapeutic strategy
was encouraged by a clinical study on treatment of re-
lapses of chronic suppurative otitis media using a prep-
aration containing Ag NPs. The study showed that Ag
NPs eliminated clinical symptoms and positive dynam-
ics of the objective signs of the disease, such as reduction
or termination of pathological exudation and stimulation
of the epidermization processes, which was stable during
the observation time of 6 months [19]. In order to per-
suade this novel therapy with sophisticated design, de-
tailed information on distribution and pathway of Ag NPsFigure 1 Characterization result of PVP coated Ag NPs using various an
of NPs showing the polydispersity in size and shape of the PVP coated AgNP
C) X-ray diffraction pattern for Ag NPs indicating the presence of metall
sputtering indicating the presence of high amount of organic impurities
presence of the organic components only on the surface. F) Hydrodyna
using dynamic light scattering.in the middle and inner ear is necessary but currently
lacking in the literature.
Micro computed tomography (CT) has been engaged
in middle and inner ear imaging of animals and impli-
cated to be a useful tool to trace kinetics of drugs in the
inner ear [20,21]. The gray levels in a CT slice image
correspond to X-ray attenuation, which reflects the pro-
portion of X-rays scattered or absorbed as they pass
through each voxel, and is affected by the density and
composition of the material being imaged. Hence, Ag
NPs are speculated to attenuate the X-rays and be visible
in micro CT images. In the present work, first a phantom
study was performed to check the dose response of the im-
aging system. Next, an in vivo experiment was carried out
in rats by injecting Ag NP suspensions with different con-
centrations into the middle ear cavity and following the
kinetics of Ag NPs in the middle and inner ear up to 7 d.
Results
Characterization of Ag NPs and potential interaction with
artificial perilymph
The Ag NPs used in this study were highly faceted with
a mean size of 21 ± 8 nm. The particles were polydis-
persed in size and shape, as shown in Figure 1. The
transmission electron microscope (TEM) images andalytical techniques. A) Transmission electron microscopy (TEM) image
s. B) TEM particle size distribution of NPs (n = 200, mean = 21 ± 8 nm),
ic silver (ICDD 004–0783). D-E) XPS analysis on Ag NPs without any
(PVP used as a surfactant). Sputtered spectrum (E) confirms the
mic size of the NPs when suspended in deionized water, measured
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X-ray diffraction (XRD) analysis confirmed the crystal-
line nature of the particles (ICDD: 004–0783). The mean
hydrodynamic size of the particles when suspended in
deionized water was 117 ± 24 nm, and the zeta potential
was measured to be −20 ± 9 mV. Inductively coupled
plasma measurements on the particles showed a very
low level of species other than silver, which were mostly
cations (Figure 2). Because the nanoparticles were sta-
bilized in the suspension using polyvinylpyrrolidone
(PVP), XPS analysis was performed to characterize the
surface of the particles. The un-sputtered spectrum of
the particles showed a high presence of organic car-
bon, which was evidently due to the presence of PVP
used as the capping agent/surfactant. However, after
increasing the sputtering time, the Ag 3 d peak started
to appear stronger, suggesting a core shell structure
wherein the core was metallic silver and the shell was
composed of an organic coating with PVP. Incubation
with artificial perilymph for 4 h did not significantly
affect the size distribution of the Ag NPs (Table 1).
Sensitivity of micro CT imaging of Ag NPs
The current setup of micro CT showed a detection limit
for Ag NPs at a concentration of 37 mM. Good linearity
between the signal intensity and Ag NPs concentration
was obtained in the range of 37–370.7 mM that were dis-
solved in H2O (Figure 3). Significant correlation was ob-
served between signal intensities of Ag NPs generated in
H2O and NaCl solutions, but the H2O provided signifi-
cantly higher signal intensities than the NaCl with normal-
ized value of 1.04 (p < 0.001, paired samples t-test).
Distribution of AgNPs in the middle and inner ear and
pathways
The heterogeneous fine structures of rat cochlea were
demonstrated by iodine-contrast micro CT in Figure 4.Figure 2 Level of impurities found in the Ag NPs shown by inductiveThe optimized protocol for rat ear micro CT imaging
had a resolution of 21.9 μm, which can utilize both the
middle ear and inner ear for detecting the distribution of
the Ag NPs in both compartments. At 4 h after trans-
tympanic injection of 370.7 mM Ag NPs, the nanoparti-
cles distributed along the middle ear mucosa, diffused to
the Eustachian tube, and the extra Ag NPs flowed out
into the external ear canal. Abundant Ag NP accumula-
tion on the surface of ossicular chain and stapes artery
was detected. The Ag NPs significantly distributed in the
round window membrane and continuously moved to
the mesothelium of the scala tympani and the annular
ligament across the stapediovestibular joint, which is the
junctional site between the middle ear and vestibule
(Figure 5). At 24 h, Ag NPs showed abundant distribu-
tion on in the round window membrane and oval window,
and became more visible within the cochlea (Figure 5). Ag
NPs was detected in the middle ear mucosa at 4 h post-
transtympanic injection at 37 mM in one rat. Aggregated
Ag NPs were visualized in both middle ear and cochlea on
7 d after injection at 37 mM (Figure 5). Higher estimated
concentrations of Ag NPs in various locations of the ear
than the applied concentrations supported the aggregation
or accumulation of Ag NPs in the corresponding area
(Table 2). However, transtympanic injection of Ag NPs at
1.85 mM did not produce any signal of Ag NP at the time
points of 4 h, 24 h, and 7 d post-administration. There was
not any fluid detected in the middle ear cavity at these time
points indicating that there was no infiltration.
Discussion
The present work demonstrated that the PVP-coated Ag
NPs were visible in the ear by micro CT after transtym-
panic injection and entered in the inner ear through the
round and oval windows. The detected bright signals
in the ear by micro CT could be either aggregated Ag
NPs or silver compound formed upon contacting thely couple plasma-mass spectrometry.
Table 1 Size distribution of AgNPs in artificial perilymph
for 4 h at different dilutions
Concentration (dilution) Zmean (nm)
x10 106.9 ± 0.3
X100 102.9 ± 0.7
X1000 100.2 ± 1.0
X10000 100.7 ± 1.2
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ferent extracellular environments in the external ear
canal, middle ear, and inner ear. The plentiful peri-
lymph in the inner ear may interact with Ag NPs and
form a compound immediately after the entry. How-
ever, the incubation of Ag NPs with artificial perilymph
did not change the size distribution over a period of
25 h, suggesting that the bright signals in the ear rep-
resent the Ag NPs. It was reported that silver might be
developed as a radiographic contrast agent in dual-
energy breast X-ray imaging [22]. However, the detec-
tion sensitivity of Ag NPs by micro CT is rather low
and the detection limit is 37 mM, a concentration that
demonstrated toxicity in the rat ear [23]. These results
did not support that the current form of Ag NPs will
be used as a contrast agent for CT imaging. Clinical
feasibility, however, warrants further studies.
The oval window pathway was recently proved to be
more efficient than the round window to transport
chelated-gadolinium from the middle ear to the inner
ear in animals and human shown by MRI [24,25]. The
pathways for the Ag NPs to enter the inner ear were
clearly shown to be the round and oval windows. This
indicates that the oval window potentially has a broad
spectrum of substance transportation in addition to
chelated-gadolinium. At 24 h post-administration to the
middle ear at a concentration of 370.7 mM, Ag NPs ac-
cumulated in the round window membrane and ovalFigure 3 Sensitivity and linear correlation between signal intensity an
were dissolved in H2O at variable concentrations (mM) and imaged using m
dividing with that of the air and linear correlation with the Ag NP concent
3 = 185.4.4 mM; 3 = 278.0 mM; 4 = 370.7 mM. AU: arbitrary unit; L: linear; O:window, and concentrated in the scala tympani, which
indicates that the entry of Ag NPs into the inner ear is a
dynamic process. This conclusion was further supported
by the quantification of Ag NPs in various regions of the
ear (Table 2). Obvious Ag NP signal was detected in the
middle ear after administration at a concentration of
37.1 mM that was the lowest detection limit of the
present setup, which may result from accumulation or
aggregation of Ag NPs in the middle ear as supported by
the quantification result (Table 2). No signal was de-
tected in the inner ear when Ag NPs were administered
at a concentration of 37 mM. This might be caused by
the low sensitivity of micro CT visualization. Our ex-
planation is that the layer of Ag NPs formed on tissue
surfaces of the inner ear is too thin to raise the value of
the voxel as a result of the partial volume effect (the
grayscale value of a voxel is the volume fraction
weighted sum of all the materials present in the voxel).
A previous study demonstrated that hearing loss occurred
in rats after middle ear administration of 37.1 mM Ag
NPs, which suggests that certain amount of Ag NPs
(below the detection threshold of the micro CT) should
have entered the inner ear [23].
The long term remaining of Ag NPs in the middle ear
cavity for 7 d post-transtympanic injection supports that
Ag NP is a potential candidate to combat otitis media.
Although no signal was detected in the inner ear on 7 d
post-administration of 37.1 mM Ag NP, it did not rule
out the penetration of Ag NPs into the inner ear because
hearing loss and pathological changes were detected in
rats exposed to Ag NPs at this concentration [23].
1.85 mM Ag NPs did not generate either micro CT sig-
nal of AgNPs or infiltration in the middle ear cavity.
No infiltration indicates that 1.85 mM of Ag NPs is a safe
level for the ear, which is in accordance with our observa-
tion that neither hearing loss nor cytokine up-regulation
in the inner ear was induced by Ag NPs at this concentra-
tion (unpublished data). Importantly, 1.85 mM of Ag NPsd Ag NP concentrations shown by micro CT phantom. Ag NPs
icro CT (A). The signal intensities of each dot were normalized by
rations was estimated (B). Concentrations in A: 0 = H2O; 1=, 92.7 mM;
observed.
Figure 4 The heterogeneous fine structures of rat inner ear
were demonstrated using iodine-contrasted micro CT. BM: basilar
membrane; CN: cochlear nerve; RM: Reissner’s membrane; SA: stapedial
artery; SFP: stapes footplate; ST: scala tympani; SV: scala vestibuli; Vest:
vestibule. scale bar = 500 μm.
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infection which only demands 0.1-2 mM Ag NPs [26].
In addition, the extra Ag NPs were secreted to the
nasal pharynx through the Eustachian tube and flowed
to the external ear canal through the tympanic mem-
brane penetration. Dysfunction of the Eustachian tube is
a common complication of otitis media. The distribution
of Ag NPs in the Eustachian tube suggest that Ag NPs
may have direct effect on the extension of otitis media.
The dendrimer-stabilized silver nanoparticles, that have
similar sizes as the Ag NPs utilized in the present study,
were reportedly effective in X-ray computed tomography
(CT) imaging and stable in water, PBS buffer, fetal bovine
serum, and resistant to changes in pH and temperature
[27]. There is a possibility that the dendrimer-stabilized
silver nanoparticles may be used as a contrast agent in the
CT imaging of the external, middle, and inner ears and
the Eustachian tube in the future based on the present
results.Conclusions
The distribution of Ag NPs in the middle and inner ear
is visible by micro CT and a gradient concentration from
the middle ear to the inner ear was detected. The path-
ways for Ag NPs to be transported from the middle ear
into the inner ear are round and oval windows. This
study provided the imaging evidence that Ag NPs are
able to access various regions of the ear after intratym-
panic administration in a dosage-dependent manner,




The Ag NPs was supplied by Colorobbia (Firenze, Italy).
Ten male Sprague Dawley rats, weighing between 330 g
and 410 g, were maintained in the Experimental Animal
Unit, School of Medicine, University of Tampere, Finland.
All animal experiments were approved by the Ethical
Committee of University of Tampere (permission: ESAVI/
3033/04.10.03/2011). Animal care and experimental pro-
cedures were conducted in accordance with European le-
gislation. Two rats were assigned into each group with
respect to concentrations of AgNPs and imaging time
(Table 3). Animal care and experimental procedures were
conducted in accordance with European legislation. All
experiments were performed under general anesthesia
with intraperitoneal injection of a mixture of 0.8 mg/kg
of medetomidine hydrochloride (Domitor, Orion, Espoo,
Finland) and 80 mg/kg of ketamine hydrochloride (Ketalar;
Pfizer, Helsinki, Finland) followed by intramuscular injec-
tion of Enrofloxacin (Baytril®vet, Orion, Turku, Finland) at
a dose of 10 mg/kg to prevent potential infection. During
experiments, the animal’s eyes were protected by Visco-
tears® (Novartis Healthcare A/S, Denmark).
Characterization of Ag NPs
The Ag NPs were dispersed in water (370.7 mM) and
characterized using a range of analytical techniques, to as-
sess various physicochemical properties (eg. size, shape,
zeta potential, surface properties etc.). For TEM measure-
ments, a diluted suspension of Ag NPs was deposited on a
copper grid for TEM imaging (Hitachi 7100, 100 kV).
XRD was performed on the NPs using an Enraf-Nonius
diffractometer coupled to INEL CPS 120 position-
sensitive detector with Co-Kα radiation, and the phase
identification was performed using STOE software.
The hydrodynamic size and zeta potential of the nano-
particles were measured using a Malvern Zetasizer
(Malvern Instruments, Malvern, UK). ICP-AES (Varian
Instruments) analysis was performed to determine the
initial concentration of silver in the aqueous nanopar-
ticulate suspension and to measure the level of any im-
purities present in the matrix. X-ray photoelectron
spectroscopy (XPS, Omicron Nanotechnology) was used
to study the chemical composition and chemical state of
the Ag NPs. The XPS analyses were performed in an
ultra-high vacuum medium (pressure of 10−10 mbar) using
an Al, Kα (hν = 1486.7 eV) X-ray source, with power given
by the emission of 16 mA at a voltage of 12.5 kV. For the
silver element, the high-resolution spectra were obtained
with analyzer pass energy of 50 eV and a step size of
0.01 eV. The argon ion flux was employed to sputter the
Figure 5 Distribution of Ag NPs in the ear after transtympanic injection shown by micro CT. Either 370.7 mM (A-E, G) or 37.1 mM (H) of
Ag NPs were injected at a volume of 50 μl. At 4 h post-administration (370.7 mM), AgNPs generated bright signal that appeared in the bulla,
tympanic membrane (TM) Eustachian tube (ET), and the ossicular chain including malleus (Ma), incus (Inc) and stapes (Sta) (A-C). Abundant
Ag NPs were found in the stapedial artery (SA) (C). At 24 h (370.7 mM), abundant distribution of AgNPs was detected in the round window
membrane (RWM), oval window (OW), and scala tympani medial wall (STM) of the cochlea (D, E, G). On 7 d (37 mM), middle ear infiltration
(IF) and AgNP aggregation (A-AgNPs) were observed (H). No Ag NPs were detected in the ear of non-treatment control (NC) (F). Coch: cochlea;
LPI: lenticular process of incus; SF: stapes footplate; ST: scala tympani. Scale bars = 5 mm (A), 2 mm (B, F), 1 mm (C-E). A-F, H: 4x, Pixel size 21.8498; G:
10x, pixel size 1.7 um.
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of 3.5 kV, emission of 20 mA, and incidence angle of 45°
over a period of 20 and 40 min. The binding energies were
referred to the carbon 1 s level, which was set as 284.6 eV.
Potential impact of perilymph on Ag NPs
Since the Ag NPs will interact with perilymph once enter
the inner ear, the potential impact of perilymph on Ag
NPs was evaluated. The artificial perilymph containing
145.5 mM NaCl, 2.7 mM KCl, 2.0 mM MgSO4, 1.2 mM
CaCl2, and 5.0 mM HEPES, with the pH adjusted to 7.4,was prepared as previously reported [28]. Ag NPs were di-
luted with artificial perilymph at 10, 100, 1000 and 10000-
fold and stored at room temperature for 4 h before the
size distribution was measured using DLS (Malvern Zeta
Sizer Nano ZS, UK). For the change in the DLS over 25 h,
the dilutions were 10-fold.
Micro CT studies
Phantom study
The first round experiment was designed to check the
sensitivity of the imaging system using solutions of Ag




Time ME ME-flu Mall Inc Stap StapArt StapFoot OW RWM Coc EEC
371 5 h 1270 547 677 500 769 1038 639 1177
371 4 h 1084 232 269 408 677 232
371 24 h 816 639 769 639 1177
371 24 h 677 593 723 1084 769 955 1177 593
37 4 h 139
37 1 w 232 93
37 1 w 185
Intensities in various locations of rat ear after transtympanic injection of AgNPs were normalized by the intensities of the cochlear perilymph imaged by μCT. The
concentrations of AgNPs were estimated using the formula of y = 4.88x-4.86 obtained in a phantom study, where “y” is the concentration and “x” is the
normalized intensity. AgNP con: AgNP concentration; Coc: cochlea; EEC: external ear canal; Inc: incus; ME: middle ear mocusa; ME-flu: middle ear fluid; Mall:
malleus; OW: oval window; RWM: round window membrane; Stap: stapes; StapArt: stapedial artery.
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3.7 mM, 0.37 mM, and 0.037 mM) that were prepared with
either deionized H2O or saline and placed into plastic
phantom tubes arranged concentrically on the modified
piston rod of a 50 ml syringe. Negative controls were pre-
pared using saline. Each sample was prepared in duplicate.
The phantom was firmly installed on the specimen stage of
the MicroXCT-400 (Carl Zeiss X-ray Microscopy, Inc,
Jena, Germany) and imaged using the following parame-
ters: Voltage 120 kV, current 83 μA, pixel size 33.95 μm,
exposure time 0.5 s. The detection limit of the imaging sys-
tem with the defined parameters was shown to be
37.1 mM based on the first round experiment. The sec-
ond round experiment was performed using solutions
of Ag NPs with smaller concentration range (370.7 mM,
278.0 mM, 185.4 mM, 92.7 mM) suspended in H2O ac-
cording to the above protocol to determine the accur-
ate correlation between the concentration and signal
intensity.
Animal study
Under general anesthesia, 50 μl of Ag NPs at defined
concentrations were injected into the left middle ear
cavity through the tympanic membrane penetration
under an operating microscope according to a previously
reported procedure [29]. After injection, the animals
were kept in the lateral position with the injected ear
oriented upward for 15 min to ensure the sufficient
amount of Ag NPs to remain in the middle ear cavityTable 3 Assignments of rats in micro CT measurements and d
administration
AgNPs conc 370.7 mM 3
Time points 4 h* 2
Locations of AgNPs in the ear ME, OC, SA, RWM, OW, ET, ST M
*Two rats were assigned into each group. conc: concentration; ET: Eustachian tube
RWM: round window membrane; SA: stapes artery; ST: scala tympani.before intraperitoneal injection of Antisendan (atipame-
zole hydrochloride, Orion Pharma, Finland) (2 mg/kg) to
accelerate recovery from anesthesia. At certain observa-
tion time points post-administration (Table 3), animals
were injected intraperitoneally with pentobarbital sodium
at a dosage of 100 mg/kg. The temporal bones were fixed
through cardiac perfusion with 0.01 M PBS containing
0.6% (v/v) heparin (pH 7.4) and then 4% paraformalde-
hyde (Merck, Espoo, Finland).After decapitation, the ani-
mal head was further fixed with 4% paraformaldehyde for
2 h, covered with parafilm, and placed on the specimen
stage of the micro CT. During imaging, three objectives
were used, 1X for the large field of view images, 4X for
the images that were focused onto the cochlea, 10x for im-
aging the oval and round windows. The voltage varied
from 60 to 120 kV, the source distance was adjusted to
60–100 mm, and the detector distance was 38–40 mm.
The pixel size ranged from 1.7 to 35.4 μm according to
different setup parameters. Afterwards, one bulla was
processed for iodine-contrast micro CT imaging in order
to demonstrate the soft tissue in the inner ear. The stapes
was displaced and about 5 μl iodixanol (VisipaqueTM,
320 g I/ml, GE Healthcare, Helsinki, Finland) was infused
into the inner ear using a high-performance polyimide
tubing (MicroLumen, Tampa, FL, USA) that was con-
nected to polyethylene tubing (PE10, Becton, Dickinson
and Company, Franklin Lakes, NJ, USA) [28].The images
were acquired with a 4x-objective, source voltage of 40 kV
and current 200 μA, pixel size of 5.6 μm. Images wereistribution of AgNPs in the ear post-intratympanic
7.1 mM 1.85 mM
4 h* 4 h* 7 d2* 7 d*
E, OC, SA, RWM, OW, ET, ST ND ME ND
; ME: middle ear; ND: not detected; OC: ossicular chain; OW: oval window;
Zou et al. Journal of Nanobiotechnology  (2015) 13:5 Page 8 of 9collected using the Xradia TXMController software
and reconstructed using the Xradia TXMR econstruc-
tor software.
Image analysis and statistics
Signal intensities in the region of interest were evaluated
using Image J 1.46r software (National Institutes of
Health, Bethesda, MD). Linear equation was used for the
curve estimation between Ag NP concentration and sig-
nal intensity obtained using micro CT in phantom.
Paired samples T-test (IBM SPSS statistics 20) was used
to compare the signal intensity generated by Ag NPs in
deionized H2O and NaCl solutions. Intensities in various
locations of rat ear after transtympanic injection of Ag
NPs were normalized by the intensities of the cochlear
perilymph imaged by μCT. The concentrations of Ag
NPs were estimated according to the linear curve ob-
tained in the phantom study.
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